A systematic review of RCTs and quasi-RCTs on traditional Chinese patent medicines for treatment of chronic hepatitis B

£5.50
VAT Exempt
In stock
SKU
JTCM-563

To read the full abstract subscribe to the JCM online archive

This systematic review of the use of patent herbal medicines for the treatment of hepatitis B identified 138 papers involving 16,393 patients, the methodological quality of which was generally ...
More Information
Author Zhan Tao et al
JCM Issue JCM99
Write Your Own Review
You're reviewing:A systematic review of RCTs and quasi-RCTs on traditional Chinese patent medicines for treatment of chronic hepatitis B
Your Rating

* Orders shipped outside of Europe are eligible for VAT relief and will not be charged VAT.